A review printed in JAMA Community Open up emphasizes the discrepancy among what it expenditures to supply copyright along with the retail costs individuals deal with. Regardless of the reduced creation prices, Novo Nordisk hasn't publicly disclosed precise figures for copyright or its other merchandise, Wegovy.In Oct 2024, Novo Nordisk released a